Literature DB >> 18924171

Phenotypic consequences of a novel SCO2 gene mutation.

Rob M Verdijk1, Ronald de Krijger, Kees Schoonderwoerd, Valeria Tiranti, Hubert Smeets, Lutgarde C P Govaerts, René de Coo.   

Abstract

SCO2 is a cytochrome c oxidase (COX) assembly gene. Mutations in the SCO2 gene have been associated with fatal infantile cardioencephalomyopathy. We report on the phenotype of a novel SCO2 mutation in two siblings with fatal infantile cardioencephalomyopathy. The index patient died of heart failure at 25 days of age. Muscle biopsy was performed for histology and biochemical study of the oxidative phosphorylation system complexes. The entire coding region of the SCO2 gene was sequenced. Autopsy was performed on the index patient and on a female sibling delivered at 23 weeks of gestation following termination of pregnancy during which amniocentesis and genetic testing had been performed. Muscle biopsy and biochemical analysis of heart and skeletal muscle detected a severe isolated COX-IV deficiency. Pathologic findings in both patients confirmed hypertrophic cardiomyopathy. Sequencing of the SCO2 gene showed compound heterozygous mutation; the common E140K mutation and a novel W36X nonsense mutation. Newborns with a combination of hypotonia and cardiomyopathy should be evaluated for multiple congenital anomaly syndromes, inborn errors of metabolism and mitochondrial derangements, and may require extensive diagnostic testing. Mutations in the SCO2 gene are a cause of prenatal-onset hypertrophic cardiomyopathy. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18924171     DOI: 10.1002/ajmg.a.32523

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Neonatal onset of mitochondrial disorders in 129 patients: clinical and laboratory characteristics and a new approach to diagnosis.

Authors:  Tomas Honzik; Marketa Tesarova; Martin Magner; Johannes Mayr; Pavel Jesina; Katerina Vesela; Laszlo Wenchich; Karol Szentivanyi; Hana Hansikova; Wolfgang Sperl; Jiri Zeman
Journal:  J Inherit Metab Dis       Date:  2012-01-10       Impact factor: 4.982

Review 2.  Mitochondrial cardioencephalomyopathy due to a novel SCO2 mutation in a Brazilian patient: case report and literature review.

Authors:  Juliana Gurgel-Giannetti; Guilherme Oliveira; Geraldo Brasileiro Filho; Poliana Martins; Mariz Vainzof; Michio Hirano
Journal:  JAMA Neurol       Date:  2013-02       Impact factor: 18.302

3.  Mutations in SCO2 are associated with autosomal-dominant high-grade myopia.

Authors:  Khanh-Nhat Tran-Viet; Caldwell Powell; Veluchamy A Barathi; Thomas Klemm; Sebastian Maurer-Stroh; Vachiranee Limviphuvadh; Vincent Soler; Candice Ho; Tammy Yanovitch; Georg Schneider; Yi-Ju Li; Erica Nading; Ravikanth Metlapally; Seang-Mei Saw; Liang Goh; Steve Rozen; Terri L Young
Journal:  Am J Hum Genet       Date:  2013-05-02       Impact factor: 11.025

Review 4.  An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases.

Authors:  Federica Marra; Paola Lunetti; Rosita Curcio; Francesco Massimo Lasorsa; Loredana Capobianco; Vito Porcelli; Vincenza Dolce; Giuseppe Fiermonte; Pasquale Scarcia
Journal:  Biomolecules       Date:  2021-11-04

5.  Analysis of reported SCO2 gene mutations affecting cytochrome c oxidase activity in various diseases.

Authors:  Radhika Chadha; Ritika Shah; Shalini Mani
Journal:  Bioinformation       Date:  2014-06-30

6.  Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome.

Authors:  Richard E Frye; Devin Cox; John Slattery; Marie Tippett; Stephen Kahler; Doreen Granpeesheh; Shirish Damle; Agustin Legido; Michael J Goldenthal
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

Review 7.  Blackout in the powerhouse: clinical phenotypes associated with defects in the assembly of OXPHOS complexes and the mitoribosome.

Authors:  Daniella H Hock; David R L Robinson; David A Stroud
Journal:  Biochem J       Date:  2020-11-13       Impact factor: 3.857

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.